In contrast to BRAF mutations, KRAS mutations were comparatively infrequent in serrated crypt foci (3/16), absent in dysplastic serrated adenoma (0/9), but present in 9/50 hyperplastic polyps [53, 54]. The gene discussed is BRAF; the disease is hyperplastic polyp.